Policy and Legislation
U.S. Rep. Tom Price is staunchly opposed to Obamacare and is expected to help craft its replacement.
The $6.3 billion bipartisan bill relaxes Food and Drug Administration regulations for faster approval of drugs, boosts medical research funding for such efforts as Vice President Joe Biden's cancer moonshot.
Measures helped lower these payments by $6.03 billion in 2016, federal agency says.
What Pence did with Indiana's Medicaid program may place him in a conciliatory middle ground in the political battles to come over Obamacare's future.
More than 1,455 lobbyists representing 400 companies, universities and other organizations pushed for or against a House version of a Cures bill this congressional cycle.
Under the rule, workers with annual salaries up to $47,476 would be eligible for overtime pay, almost double the current income threshold.
Until the case is resolved, insurers will continue to be paid funds on a monthly basis for covering low-income consumers on the ACA exchanges.
Health officials, policy experts call that step backwards to long waits for coverage, high prices, limited benefits and few health plan choices.
Over five years, legislation would include $550 million in additional funding for FDA, $1.75 billion annually in added spending for NIH.
Kentucky's enrollment has doubled since late 2013 and today almost a third of its residents are in the program.